Sympathetic Neurovascular Transduction: Role of Adrenergic Receptors and Sex Differences
NCT ID: NCT05997732
Last Updated: 2026-01-08
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
PHASE4
30 participants
INTERVENTIONAL
2023-10-31
2027-12-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
1. Are there sex differences in the communication between the sympathetic nervous system (also known as the "fight or flight" response) and peripheral blood vessels (which influence systemic blood pressure)?
2. What is the role of specific vascular receptors that respond to sympathetic signals, and is it different between males and females?
Participants will complete one study visit of approximately 3 hours where they will:
* Have a blood sample taken to measure circulating sex hormone and sympathetic transmitters.
* Receive very small doses of medications commonly used to adjust blood pressure through an artery in their arm. The effects of these medications will be short-acting and localized to the forearm.
* Have their sympathetic nervous activity directly measured through two very small needles (similar to acupuncture needles) in the side of their leg.
* Have their blood pressure and heart rate recorded, and forearm blood flow measured using ultrasound.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Autonomic Nervous System and Nitric Oxide Interactions
NCT01137253
Sex-related Differences in Sympathetic Vascular Transduction in the Setting of Hypoxemia
NCT05256069
Study of Norepinephrine Levels and Sympathetic Nervous System Activity
NCT00001329
Role of Acetylcholine in Blood Flow Regulation in Healthy Adults: Effects of Age and Exercise Training
NCT03972683
Early Neurovascular Adaptations in Aging Women
NCT06520982
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Males and females regulate their blood pressure in different ways; for example, females tend to have lower blood pressure and sympathetic nerve activity than males. Females also appear to have less constriction of their blood vessels in response to stress. This may be due to differences in the receptors which are activated by the sympathetic nervous system. These receptors are called α and β-adrenergic receptors and are located on vascular smooth muscle cells. They respond to sympathetic neurotransmitters such as norepinephrine in opposite directions: α-adrenoreceptors cause vasoconstriction (and an increase in vascular resistance), and β-adrenoreceptors cause vasodilation (and a decrease in vascular resistance) in part through the endothelium-dependent nitric oxide pathway.
Current evidence suggests that β-adrenergic receptors are more sensitive in females and contribute to paradoxical vasodilation when α-adrenergic receptors are stimulated by norepinephrine from sympathetic bursts. It has also been suggested that estrogen interacts with adrenergic receptors, contributing to this sex difference. This study will contribute to the understanding of sex differences in cardiovascular physiology and may have implications for clinical cardiovascular conditions.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
CROSSOVER
BASIC_SCIENCE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Control Condition
Normal saline will be infused through the brachial artery catheter at the same calculated rate as propranolol + phentolamine in the α+β-blockade condition to control for volumetric effects.
Phenylephrine Hydrochloride
Participants will receive three incremental doses via the brachial artery catheter to assess α1-adrenoreceptor mediated vasoconstriction.
Isoproterenol Hydrochloride
Participants will receive four incremental doses via the brachial artery catheter to assess β-adrenoreceptor mediated vasodilation.
Norepinephrine Bitartrate
Participants will receive three incremental doses via the brachial artery catheter to assess nonspecific adrenoreceptor activation.
β-Adrenergic Blockade
β-adrenoreceptors will be blocked locally in the forearm using propranolol. Normal saline will be co-infused at the calculated rate of phentolamine in the α+β-blockade condition to control for volumetric effects.
Norepinephrine Bitartrate
Participants will receive three incremental doses via the brachial artery catheter to assess nonspecific adrenoreceptor activation.
Propranolol Hydrochloride
Propranolol will be continuously infused through the brachial artery catheter to induce β-adrenergic blockade locally in the forearm.
α+β-Adrenergic Blockade
α-adrenoreceptors will be blocked locally in the forearm using phentolamine. Propranolol will be co-infused to maintain β-blockade.
Phentolamine Mesylate
Phentolamine will be continuously infused through the brachial artery catheter to induce α-adrenergic blockade locally in the forearm.
Phenylephrine Hydrochloride
Participants will receive one dose via the brachial artery catheter to evaluate the effectiveness of the α-adrenergic blockade.
Isoproterenol Hydrochloride
Participants will receive one dose via the brachial artery catheter to evaluate the effectiveness of the β-adrenergic blockade.
Propranolol Hydrochloride
Propranolol will be continuously co-infused with phentolamine to maintain the β-adrenergic blockade.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Phenylephrine Hydrochloride
Participants will receive three incremental doses via the brachial artery catheter to assess α1-adrenoreceptor mediated vasoconstriction.
Isoproterenol Hydrochloride
Participants will receive four incremental doses via the brachial artery catheter to assess β-adrenoreceptor mediated vasodilation.
Norepinephrine Bitartrate
Participants will receive three incremental doses via the brachial artery catheter to assess nonspecific adrenoreceptor activation.
Propranolol Hydrochloride
Propranolol will be continuously infused through the brachial artery catheter to induce β-adrenergic blockade locally in the forearm.
Phentolamine Mesylate
Phentolamine will be continuously infused through the brachial artery catheter to induce α-adrenergic blockade locally in the forearm.
Phenylephrine Hydrochloride
Participants will receive one dose via the brachial artery catheter to evaluate the effectiveness of the α-adrenergic blockade.
Isoproterenol Hydrochloride
Participants will receive one dose via the brachial artery catheter to evaluate the effectiveness of the β-adrenergic blockade.
Propranolol Hydrochloride
Propranolol will be continuously co-infused with phentolamine to maintain the β-adrenergic blockade.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* No diagnosed medical history of cardiovascular, respiratory, nervous system, or metabolic disease.
* Females must be pre-menopausal.
* Prior to study visit: abstained from caffeine, alcohol, strenuous exercise, and medication not taken regularly for at least 12 hours.
Exclusion Criteria
* Participants with bleeding or clotting disorders, or those currently taking blood thinners.
* Participants currently taking beta-agonist inhalers i.e. Ventolin (at least not in the last 24 hours).
* Females who are pregnant, confirmed by a pregnancy test.
* Females who have are less than 1 year postpartum or are breastfeeding.
* Females who are post-menopausal.
* Participants that are classified as obese (body mass index \> 30 kg ⋅ m2).
* Those with a known allergy to sulfites, or other components of the supplied solution of study drugs.
* Participants taking medications that are contraindicated with any of the study drugs, such as monoamine oxidase (MAO) inhibitors or tricyclic antidepressants.
* Participants who have not adhered to the pre-testing guidelines related to diet, alcohol or exercise will not be excluded, but will be rescheduled for a different day. This is to reduce experimental variability.
18 Years
40 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Alberta
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Sean van Diepen, MD, MSc
Role: PRINCIPAL_INVESTIGATOR
University of Alberta
Craig Steinback, PhD
Role: PRINCIPAL_INVESTIGATOR
University of Alberta
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Alberta
Edmonton, Alberta, Canada
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
References
Explore related publications, articles, or registry entries linked to this study.
Hart EC, Charkoudian N, Wallin BG, Curry TB, Eisenach JH, Joyner MJ. Sex differences in sympathetic neural-hemodynamic balance: implications for human blood pressure regulation. Hypertension. 2009 Mar;53(3):571-6. doi: 10.1161/HYPERTENSIONAHA.108.126391. Epub 2009 Jan 26.
Steinback CD, Fraser GM, Usselman CW, Reyes LM, Julian CG, Stickland MK, Chari RS, Khurana R, Davidge ST, Davenport MH. Blunted sympathetic neurovascular transduction during normotensive pregnancy. J Physiol. 2019 Jul;597(14):3687-3696. doi: 10.1113/JP277714. Epub 2019 Jun 13.
Fairfax ST, Holwerda SW, Credeur DP, Zuidema MY, Medley JH, Dyke PC 2nd, Wray DW, Davis MJ, Fadel PJ. The role of alpha-adrenergic receptors in mediating beat-by-beat sympathetic vascular transduction in the forearm of resting man. J Physiol. 2013 Jul 15;591(14):3637-49. doi: 10.1113/jphysiol.2013.250894. Epub 2013 May 7.
Dinenno FA, Eisenach JH, Dietz NM, Joyner MJ. Post-junctional alpha-adrenoceptors and basal limb vascular tone in healthy men. J Physiol. 2002 May 1;540(Pt 3):1103-10. doi: 10.1113/jphysiol.2001.015297.
Hissen SL, Taylor CE. Sex differences in vascular transduction of sympathetic nerve activity. Clin Auton Res. 2020 Oct;30(5):381-392. doi: 10.1007/s10286-020-00722-0. Epub 2020 Aug 31.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Pro00126600
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.